Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Brain Stimulation and Electrical Stimulation to Help Hand Control After Stroke

Tests brain stimulation with muscle electrical stimulation in adults with hand weakness after stroke.

Plain-language title generated from the registry record
Registry title: Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation

Key facts

Where
Cleveland, United StatesSee the site

Where in United States

  • MetroHealth Medical CenterCleveland, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
MetroHealth Medical Center
Trial code
NCT03857529
Record updated
29 September 2025
Original description
This pilot study for stroke patients with chronic upper limb hemiplegia will examine the effects of non-invasive brain stimulation and neuromuscular electrical stimulation on hand motor control and corticospinal excitability. Specifically, this study will investigate the effects of timing and delivery of tDCS in conjunction with contralaterally controlled functional electrical stimulation.Read full original descriptionShow less

Contralaterally Controlled FES Plus Transcranial Direct Current Stimulation for Hand Motor Control After Stroke: A Pilot Study

This pilot study for stroke patients with chronic upper limb hemiplegia will examine the effects of non-invasive brain stimulation and neuromuscular electrical stimulation on hand motor control and corticospinal excitability. Specifically, this study will investigate the effects of timing and delivery of tDCS in conjunction with contralaterally controlled functional electrical stimulation.

Inclusion: Age ≥ 21; ≥ 6 months since first clinical hemorrhagic or nonhemorrhagic stroke; Able to follow 3-stage commands and remember 2 of 3 items after 30 minutes; Full volitional elbow extension/flexion and hand opening/closing of unaffected limb; Adequate active movement of shoulder and elbow to position the paretic hand in the workspace for table-top task practice; Patient must be able to sit unassisted in an armless straight-back chair for the duration of the screening portion of the eligibility assessment; Medically stable; ≥ 10° finger extension; Unilateral upper limb hemiparesis with finger extensor strength of ≤ grade 4/5 on the manual muscle test AND a score of; ≥1 and ≤ 11/14 on the hand section of the upper extremity Fugl-Meyer Assessment; Skin intact on hemiparetic arm, hand and scalp; While relaxed, surface neuromuscular electrical stimulation of finger extensors and thumb extensors and/or abductors produces a functional degree of hand opening without pain; No significant visual or hearing impairment.

Exclusion: Co-existing neurological condition other than prior stroke involving the hemiparetic upper limb (e.g., peripheral nerve injury, Parkinson's disease, spinal cord injury, traumatic brain injury, multiple sclerosis); Metal implant in the head; Uncontrolled seizure disorder; Use of seizure lowering threshold medications at the discretion of the study physician (Dr. Rich Wilson); Cardiac pacemaker or other implanted electronic device and/or stent; Pregnant; Intramuscular botox injections in any upper extremity muscle in the last 3 months; Insensate arm, forearm, or hand; Severely impaired cognition and communication; Uncompensated hemi-neglect (extinguishing to double simultaneous stimulation); Severe shoulder or hand pain (unable to position hand in the workspace without pain).

ClinicalTrials.gov NCT03857529